Providing kidney transplants to patients with the best probability of longer survival would reduce repeat transplant operations and improve life span after kidney transplant, says a U-M researcher in a commentary published in the New England Journal of Medicine March 16.

Alan B. Leichtman, M.D., professor of Internal Medicine at U-M and his co-authors endorsed new concepts designed to improve kidney allocation. These concepts were circulated in February by the Organ Procurement and Transplantation Network (OPTN). The OPTN is the federal contract that oversees solid organ recovery and allocation in the United States.

“We strongly support the concept of rank ordering donated kidneys based upon their potential post-transplant survival, and matching that survival to that of waitlisted kidney transplant candidates,” says Leichtman, the commentary’s lead author.

“The current deceased donor kidney allocation system allows distribution of kidneys with very short potential survival to candidates with long expected survival. Candidates with long potential lifetimes that received kidneys with short expected survival have twice the repeated transplantation rate than similar recipients who received organs with a longer expected survival rate.”

The current U.S. deceased donor kidney allocation system relies primarily upon how long a candidate has been waiting for an organ. However, systems for liver and heart transplantation allocation are based upon candidate medical urgency. The lung allocation system allocates organs based upon a mixture of medical urgency and expected one-year post-transplant survival.

The Organ Procurement and Transplantation Network has released for public comment three proposed concepts for deceased donor kidney allocation.

1) Using a Kidney Donor Profile Index to rank deceased donor kidneys according to the length of time that the kidney would be expected to function in an average kidney transplant recipient.

2) Allocating the 20% highest quality kidneys to the 20% of candidates with the longest expected post-transplant survival.

3) Allocating the remaining 80% of kidneys such that candidates who are within 15 years (older or younger) of the donor’s age have highest priority.

Because of the current system and the aging of the candidate pool, post-transplant life span following kidney transplantation in the United States has declined on average by 18 months since 1995, Leichtman says.

The authors say that computer simulations based on the current donor pool suggest that more than 35,000 years of post-transplant survival are lost each year under the current system. Additionally, more than 10,000 years of incremental post-transplant survival — extra years of life that would not have been achieved without the benefit of transplant — also are lost each year.

“We are wasting hundreds of thousands of potential years of life,” Leichtman says. “The proposal for survival matching as described in the concept document has the potential to reclaim many of these lost years of life, and therefore warrants serious consideration.”

The authors also support using the proposed Kidney Donor Profile Index. The new index provides a more granular and accurate survival estimate for organs.

“We suspect that utilization rates of shorter-lived kidneys will increase with accurate information about their survival potential and reduced opportunity for potentially short-lived candidates to be allocated kidneys with long estimated post-transplant survival,” the authors wrote.

About 80,000 people are listed nationwide for a kidney transplant. Demand continues to increase, some of it driven by an unnecessarily high rate of repeat transplantations because kidneys and recipients weren’t well matched, says Leichtman.

Kidney transplants are the most common transplants done at the University of Michigan Transplant Center and nationwide. But more than half of those who get wait-listed for a kidney transplant in the U.S. never receive a transplant.

“The lost potential life years, and the increase in the waiting list resulting from an unnecessarily high rate of repeat transplantation are intolerable consequences of the current kidney transplant allocation system,” Leichtman says. “There likely are further opportunities for improvements to the proposed system, but the core proposals presented in the concept document, adoption of the KDPI and survival matching, warrant the strongest endorsement and the earliest possible implementation by the kidney transplant community.”

Public comment is open until April 1 on the proposed concepts. Comments can be e-mailed to kidneypolicyunos.

Journal citation: 10.1056/NEJMp1102728

Additional authors: Robert A. Wolfe, Ph.D., professor emeritus in the University of Michigan School of Public Health and Keith P. McCullough. M.S. Both Dr. Wolfe and Mr. McCullough are investigators at the Arbor Research Collaborative for Health in Ann Arbor, Mich.

Source:
University of Michigan Health System

Comments are closed.

Buy Carbamazepine without Prescripton
Buy Atenolol without Prescripton
Buy Oxytetracycline without Prescripton
Buy Tetracycline Hydrochloride without Prescripton
Buy Theophylline (Theo-24 Cr) without Prescripton
Buy Theophylline (Theo-24 Sr) without Prescripton
Buy Chlorpromazine without Prescripton
Buy Ticlopidine without Prescripton
Buy Tinidazole without Prescripton
Buy Imipramine without Prescripton
Buy Topiramate without Prescripton
Buy Metoprolol (Toprol) without Prescripton
Buy Metoprolol (Toprol Xl) without Prescripton
Buy Labetalol without Prescripton
Buy Ethionamide without Prescripton
Buy Pentoxifylline without Prescripton
Buy Fenobibrate without Prescripton
Buy Oxcarbazepine without Prescripton
Buy Amoxicillin (Trimox) without Prescripton
Buy Ramipril (Tritace) without Prescripton
Buy Theophylline (Uniphyl Cr) without Prescripton
Buy Flavoxate Hcl without Prescripton
Buy Alfuzosin without Prescripton
Buy Ursodiol without Prescripton
Buy Valproic Acid without Prescripton
Buy Valacyclovir without Prescripton
Buy Cefpodoxime without Prescripton
Buy Enalapril without Prescripton
Buy Venlafaxine (Venlor) without Prescripton
Buy Salbutamol without Prescripton
Buy Verapamil HCl without Prescripton
Buy Arpamyl without Prescripton
Buy Mebendazole without Prescripton
Buy Doxycycline (Vibramycin) without Prescripton
Buy Nevirapine without Prescripton
Buy Methylcobalamin without Prescripton
Buy Ascorbic Acid without Prescripton
Buy Diclofenac (Voltaren) without Prescripton
Buy Diclofenac (Voltaren Xr) without Prescripton
Buy Diclofenac (Voltarol) without Prescripton
Buy Diclofenac (Voveran) without Prescripton
Buy Diclofenac (Voveran SR) without Prescripton
Buy Bupropion (Wellbutrin) without Prescripton
Buy Bupropion (Wellbutrin SR) without Prescripton
Buy Latanoprost without Prescripton
Buy Capecitabine without Prescripton
Buy Drospirenone/Ethinyl Estradiol without Prescripton
Buy Sparfloxacin without Prescripton
Buy Tizanidine without Prescripton
Buy Ranitidine without Prescripton
Buy Bisoprolol without Prescripton
Buy Stavudine without Prescripton
Buy Lisinopril/Hydrochlorothiazide without Prescripton
Buy Lisinopril (Zestril) without Prescripton
Buy Ezetimibe without Prescripton
Buy Azithromycin without Prescripton
Buy Simcard without Prescripton
Buy Ondansetron without Prescripton
Buy Acyclovir without Prescripton
Buy Bupropion (Zyban) without Prescripton
Buy Allopurinol (Zyloprim) without Prescripton
Buy Olanzapine without Prescripton
Buy Cetirizine without Prescripton
Buy Linezolid without Prescripton
Buy Aripiprazole without Prescripton
Buy Quinapril without Prescripton
Buy Isotretinoin without Prescripton
Buy Perindopril (Aceon) without Prescripton
Buy Aciclovir without Prescripton
Buy Rabeprazole without Prescripton
Buy Permethrin (Acticin) without Prescripton
Buy Ursodeoxycholic acid without Prescripton
Buy Pioglitazone without Prescripton
Buy Nifedipine (Adalat) without Prescripton
Buy Aspirin/Dipyridamole without Prescripton
Buy Albendazole without Prescripton
Buy Spironolactone without Prescripton
Buy Levonorgestrel/Ethinyl estradiol without Prescripton
Buy Alfacalcidol without Prescripton
Buy Fexofendine without Prescripton
Buy Allopurinol (Allopurinol) without Prescripton
Buy Ramipril (Altace) without Prescripton
Buy Glimepiride without Prescripton
Buy Amoxicillin (Amoxil) without Prescripton
Buy Acillin without Prescripton
Buy Aspirin/Caffeine without Prescripton
Buy Clomipramine HCI without Prescripton
Buy Naproxen (Anaprox) without Prescripton
Buy Flurbiprofen without Prescripton
Buy Disulfiram without Prescripton
Buy Meclizine without Prescripton
Buy Chloroquine without Prescripton
Buy Leflunomide without Prescripton
Buy Etoricoxib without Prescripton
Buy Donepezil without Prescripton
Buy Anastrozole without Prescripton
Buy Triamcinolone without Prescripton
Buy Trihexyphenidyl without Prescripton
Buy Mesalamine (Asacol) without Prescripton
Buy Amoxapine without Prescripton